BSE:GODAVARI   GODAVARI DRUGS LTD.
Inverse H&S / C&H Formation: Yearly Basis
C&H Price Trendline BreakOut
Vol. Consolidation/BreakOut

*With Upside, Trail SL*
*Book Profit as per Risk Appetite*

*Snapshot*
Estab. in 1987, engaged in manufacturing of APIs

Revenue /Profit Stable on Qtrly/Yrly Basis. Gaining Traction.
Moderate Leverage Growing TNW. Profits Retained
CF for Ops. Increasingly +ve
Improved RoA/RoE/RoCE for FY22.
Promoters Stake Up Since Mar’22 / DII Stake Stable

*Concern:*
High Revenue Dependence on Ciprofloxacin API
High Public Stake at 42.58%

*Do Your Own Research as Well. This is Just an Opinion.*
Happy Investing :)

Clause de non-responsabilité

Les informations et les publications ne sont pas destinées à être, et ne constituent pas, des conseils ou des recommandations en matière de finance, d'investissement, de trading ou d'autres types de conseils fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.